510(k) Report

PMA · Approved

Recalled · Class II · 2020

Barricaid Anular Closure Device (Acd)

P160050PMAApproved Feb 8, 2019820-day reviewClass IIIRecalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Intrinsic Therapeutics · QES Reherniation Reduction Device

Approved on Feb 8, 2019 through premarket approval, which rests on the device’s own clinical evidence after an 820-day review. It has been recalled once.

Decided
Feb 8, 2019
Review
820 days
Class
Class III
Product code
QES
Recalls
1

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P160050 has 11 supplements since 2019: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2019: 22020: 32023: 12024: 22025: 22026: 1
2019high 3 (2020) · low 0 (2021)2026
View FIG. 1 as a table
YearSupplements approved
20192
20203
20231
20242
20252
20261
FIG. 1 — Supplements to P160050, 2019–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in QES? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jul 24, 2020Class IIZ-2798-2020Process controlThe catalog ( REF ) number on the peelable inner labels (patient sticker) that is on the inner container (box) is incorrect. It states BAR-A8-10MM instead of BAR-A8-8MM.

No ancestor or descendant has a Class I recall.

How does its category compare?

All QES devices

QES Reherniation Reduction Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · QES

2in 2025

2019: 32020: 32023: 12024: 22025: 22026 (partial year): 1
2007high 3 (2019) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · QES

Too few QES 510(k)s in any year since 2007 to give a median.

Recalls per year · QES

No recall names QES since 2007.

Adverse event reports per year · QES

38in 2025

2020: 192021: 182022: 222023: 182024: 232025: 38
2007high 38 (2025) · low 0 (2007)2025

MAUDE reports naming product code QES, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20193—00
20203—019
20210—018
20220—022
20231—018
20242—023
20252—038
20261—0—
Cite this page

510(k) Report. “P160050: Barricaid Anular Closure Device (Acd).” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/P160050

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026